Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Cellebrite DI (CLBT) Invested Capital (2019 - 2025)

Cellebrite DI has reported Invested Capital over the past 7 years, most recently at $484.3 million for Q4 2025.

  • Quarterly results put Invested Capital at $484.3 million for Q4 2025, up 44.13% from a year ago — trailing twelve months through Dec 2025 was $484.3 million (up 44.13% YoY), and the annual figure for FY2025 was $484.3 million, up 44.13%.
  • Invested Capital for Q4 2025 was $484.3 million at Cellebrite DI, up from $336.0 million in the prior quarter.
  • Over the last five years, Invested Capital for CLBT hit a ceiling of $484.3 million in Q4 2025 and a floor of -$73.3 million in Q4 2021.
  • Median Invested Capital over the past 5 years was $73.9 million (2022), compared with a mean of $171.0 million.
  • Biggest five-year swings in Invested Capital: tumbled 214.96% in 2021 and later skyrocketed 882.17% in 2024.
  • Cellebrite DI's Invested Capital stood at -$73.3 million in 2021, then surged by 200.71% to $73.9 million in 2022, then crashed by 53.68% to $34.2 million in 2023, then skyrocketed by 882.17% to $336.0 million in 2024, then skyrocketed by 44.13% to $484.3 million in 2025.
  • The last three reported values for Invested Capital were $484.3 million (Q4 2025), $336.0 million (Q4 2024), and $34.2 million (Q4 2023) per Business Quant data.